Published in

Elsevier, Clinical Breast Cancer, 2(11), p. 103-113

DOI: 10.1016/j.clbc.2011.03.003

Links

Tools

Export citation

Search in Google Scholar

Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2+ Metastatic Breast Cancer: HERTAX Trial

Journal article published in 2011 by Paul Hamberg, Monique M. E. M. Bos, Hans J. J. Braun, Jacqueline M. L. Stouthard, Gert A. van Deijk, Frans L. G. Erdkamp, Iris N. van der Stelt-Frissen, Marijke Bontenbal, Geert-Jan M. Creemers, Johanneke E. A. Portielje ORCID, Johannes F. M. Pruijt, Olaf J. L. Loosveld, Willem M. Smit, Erik W. Muller, Paul I. M. Schmitz and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO